LORRAIN DANIEL S. (Chief Scientific Officer) sold 2.9% of their position (4.17K shares) of CONTINEUM THERAPEUTICS, INC. on the open market
Open‑market sale worth $54.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/1/2026ACC: 0001628280-26-039641
Officer· Chief Scientific Officer
Since Mar 2026
-4.17K
Net shares
Net seller
$54.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4.17K disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−4.17K
Price / share
$13.16
Trade value
$54.86K
% of position
2.9%
6/1/2026
143.54K→139.37K
Total
Net shares
−4.17K
Net value
-$54.86K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 6/1/2026 | S · Sale | −4.17K | $13.16 | $54.86K | 2.9% | 143.54K | 139.37K |
| Total | −4.17K | -$54.86K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Class A Common Stock
IndirectShares owned10.11K
Total
10.11K indirect10.11K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock | 10.11K | Indirect |
| Total | 10.11K | 10.11K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported